Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention

Published:2006 Issue:5 Volume:68 Page:671-676
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Huang Raymond I.,Patel Parul,Walinsky Paul,Fischman David L.,Ogilby J. David,Awar Mark,Frankil Craig,Savage Michael P.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Reference36 articles.

1. No-Reflow Phenomenon

2. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.

3. Features and outcome of no-reflow after percutaneous coronary intervention

4. No-reflow phenomenon during percutaneous transluminal coronary angioplasty

5. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Intracoronary Adrenaline in the Treatment of No-Reflow Phenomenon in Patients Undergoing Percutaneous Coronary Intervention;Cureus;2024-05-15

2. The Role of Microvascular Obstruction and Intra-Myocardial Hemorrhage in Reperfusion Cardiac Injury. Analysis of Clinical Data;Reviews in Cardiovascular Medicine;2024-03-14

3. Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention;Reviews in Cardiovascular Medicine;2023-12-25

4. Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction;Nature Reviews Cardiology;2023-11-24

5. Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy;Journal of Clinical Medicine;2023-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3